Simplex Trading
AVIR icon

Simplex Trading’s Atea Pharmaceuticals AVIR Stock Holding History

Simplex Trading’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.6K Buy
6,244
+4,349
+229% +$20K ﹤0.01% 6272
2025
Q4 		$6.76K Sell
1,895
-44,325
-96% -$141K ﹤0.01% 7245
2025
Q3 		$134K Sell
46,220
-14,364
-24% -$49K ﹤0.01% 5413
2025
Q2 		$218K Buy
+60,584
New +$181K ﹤0.01% 4415
2025
Q1 		– Sell
-3,426
Closed -$10.7K – 8495
2024
Q4 		$11K Sell
3,426
-15,605
-82% -$51.9K ﹤0.01% 7108
2024
Q3 		$63K Sell
19,031
-71,306
-79% -$259K ﹤0.01% 5671
2024
Q2 		$299K Sell
90,337
-26,318
-23% -$98.1K ﹤0.01% 4224
2024
Q1 		$471K Buy
116,655
+103,197
+767% +$404K ﹤0.01% 3922
2023
Q4 		$41K Buy
13,458
+11,264
+513% +$34.1K ﹤0.01% 6270
2023
Q3 		$6K Sell
2,194
-3,906
-64% -$13.3K ﹤0.01% 7501
2023
Q2 		$22K Buy
6,100
+483
+9% +$1.81K ﹤0.01% 6657
2023
Q1 		$18K Buy
+5,617
New +$22.8K ﹤0.01% 6995
2022
Q2 		– Sell
-117,345
Closed -$801K – 9915
2022
Q1 		$847K Buy
117,345
+83,810
+250% +$569K ﹤0.01% 3108
2021
Q4 		$299K Buy
+33,535
New +$523K ﹤0.01% 4575

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Simplex Trading's AVIR Position: Q1 2026 in Review

Simplex Trading increased its Atea Pharmaceuticals (AVIR) stake by 229% in Q1 2026, buying an estimated $20K and bringing the position to 6,244 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6272.

Simplex Trading first reported a position in AVIR in Q4 2021 and has held it in 14 quarters since. The position peaked at $847K in Q1 2022. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Simplex Trading held 6,244 shares of Atea Pharmaceuticals worth $33.6K as of Q1 2026.
  • Simplex Trading bought 4,349 Atea Pharmaceuticals shares in Q1 2026, an estimated $20K.
  • Atea Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6272 holding.
  • Simplex Trading first reported a position in Atea Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
  • Simplex Trading's Atea Pharmaceuticals position peaked at $847K in Q1 2022.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.